Healthcare >> CEO Interviews >> March 17, 2009
STEWART D. CHIPMAN is Executive Vice President and Chief Scientific Officer of
Aequus BioPharma, Inc. He is co-inventor of the Genetic Polymer technology,
Vice President of Research at Cell Therapeutics, Inc., and a biotech executive
with over 15 years of experience in building and leading scientific teams
focused on the discovery and development of novel human therapeutics in the
fields of inflammation, metabolic bone diseases and cancer biology. As Director
of Biomolecular Screening at Immunex and Associate Director, Research at Amgen,
Dr. Chipman provided expertise in high-throughput screening robotics and
synthetic chemistry for small molecule lead discovery. Prior to joining Immunex,
he was Director of Biology at ArQule in Boston. Dr. Chipman received his BS in
Biology at Boston University and PhD in Biochemistry from the Boston University
School of Medicine. Prior to pursuing his career in biotech, Dr. Chipman was an
Associate Professor of Medicine at The Johns Hopkins University Medical School.
He has co-authored more than 40 peer-reviewed scientific papers and is a co-
inventor on seven US and foreign patents. Profile
picture of the things you're doing now.
Dr. Chipman: Aequus Biopharma was formed as a majority owned subsidiary of
